We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus (VINOH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01797627
Recruitment Status : Active, not recruiting
First Posted : February 22, 2013
Last Update Posted : October 30, 2017
Information provided by (Responsible Party):

June 8, 2012
February 22, 2013
October 30, 2017
August 2011
July 2017   (Final data collection date for primary outcome measure)
Association between ventricle size and neuropsychological outcome [ Time Frame: 6 months after initial surgical treatment for hydrocephalus ]
Ventricle size, measured as fronto-occipital horn ratio (FOR), as well as neuropsychological outcomes at 6 months post-surgical intervention for initial treatment of hydrocephalus will be compared.
Same as current
Complete list of historical versions of study NCT01797627 on ClinicalTrials.gov Archive Site
  • Quality of life [ Time Frame: 6 months after initial surgical treatment for hydrocephalus ]
    The Hydrocephalus Outcome Questionnaire (HOQ) will be administered at approximately 6 months. The HOQ is a validated measure of quality of life specific to the pediatric hydrocephalus population.
  • Academic Performance [ Time Frame: 6 months after initial surgical treatment for hydrocephalus ]
    Parents will be asked to provide a picture of their child's current academic performance. If available, the child's most recent grade point average (GPA) will be obtained.
  • Presence of additional required hydrocephalus related surgeries [ Time Frame: 6 months after initial surgical treatment for hydrocephalus ]
    Shunt and ETV revisions or infections will be examined for any correlations with cognitive neuropsychological testing at 6 months from the initial surgical intervention.
Same as current
Not Provided
Not Provided
Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus
Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus (VINOH)
This multicenter, prospective study of children with hydrocephalus will examine whether or not ventricle size is associated with poor cognitive outcomes. It is expected that results will indicate larger ventricular size at 6 months after surgery for the initial treatment of hydrocephalus will relate to poorer cognitive outcomes. This study is being conducted by the Hydrocephalus Clinical Research Network (HCRN), a network established to conduct multi-institutional clinical trials on pediatric hydrocephalus.
The current literature is inconclusive regarding the direct association between large ventricle size and poorer cognitive outcomes. This uncertainty stems from relatively few studies, problems with study design (possible confounding factors), varying study populations of hydrocephalus, and conflicting evidence. If the association is proven then aggressive strategies must be developed to maximally decrease ventricular size in these children to preserve long-term cognitive functioning. However, if the association is disproven then previous reservations for procedures such as Endoscopic Third Ventriculostomy (ETV) or higher-resistance shunting to prevent overdrainage complications will be further minimized. Either finding has a major potential to further improve the quality of life in our pediatric hydrocephalus patients. This study is unique as it will include pediatric patients presenting with hydrocephalus from a wide range of etiologies. This study is also unique in that we propose to conduct a brief pre-operative neuropsychological examination to act as internal controls along with the outcomes obtained at a more extensive neuropsychological examination at six months after initial hydrocephalus treatment surgery.
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Pediatric, school-aged patients presenting with a first time diagnosis of hydrocephalus.
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Active, not recruiting
July 2018
July 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria: Patients will be eligible for enrollment if they:

  • are 5 years of age or older; and
  • have been newly diagnosed with hydrocephalus to be managed surgically with either a cerebrospinal fluid (CSF) shunt or an ETV; and
  • have one of the following etiologies for hydrocephalus: aqueductal stenosis, supratentorial and posterior fossa tumors both benign and malignant, post-traumatic, myelomeningocele, tectal gliomas, post-infectious, and following spontaneous intraventricular hemorrhage (IVH). Malignant tumors have been included as the neuropsychological deficits secondary to adjuvant chemotherapy and radiation have not been demonstrated within the proposed study's 6 month window.

Exclusion Criteria: Patients will be ineligible for enrollment if ANY of the following is true or anticipated:

  • present with a Glasgow Coma Scale (GCS) score of less than 14/15, cerebellar mutism, or cognitive deficits so severe as to make neuropsychological testing impossible; OR
  • have etiologies of diffuse intrinsic pontine glioma, atypical teratoid rhabdoid tumor, or any tumor with cerebral or spinal metastases (these patients' clinical course and survival are highly unpredictable); OR
  • are not expected to survive for 6 months; OR
  • are unable or unwilling to participate in the study and with the neuropsychological exam; OR
  • due to limitations of neuropsychological testing, blind and deaf children will be excluded. Children for whom English is not their primary language will be included if they have attended 1 or more years of English language based schooling.
Sexes Eligible for Study: All
5 Years to 17 Years   (Child)
Contact information is only displayed when the study is recruiting subjects
Canada,   United States
1RC1NS068943-01 ( U.S. NIH Grant/Contract )
HCRN 006 ( Other Identifier: HCRN Protocol Number )
Not Provided
Plan to Share IPD: No
richard holubkov, University of Utah
University of Utah
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • Hydrocephalus Association Mentored Young Investigator Award
Study Chair: Jay Riva-Cambrin, MD, MSc Alberta Children's Hospital
Principal Investigator: Richard Holubkov, Ph.D. University of Utah
University of Utah
October 2017